Week 11 Reverse Flashcards

1
Q

Bind to GABA-A receptors, enhancing the inhibitory effect of GABA by increasing chloride influx, leading to neuronal hyperpolarization and decreased excitability.

A

Benzodiazepines: MOA in Seizure Management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Used acutely for seizure emergencies like status epilepticus (e.g., diazepam, lorazepam). Chronic use is limited due to tolerance; clobazam and clonazepam may be used for specific seizure types.

A

Benzodiazepines: Acute vs. Chronic Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

IV lorazepam preferred for status epilepticus. Diazepam is available in rectal and intranasal formulations for out-of-hospital use.

A

Benzodiazepines: Routes of Administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chronic use may lead to tolerance and decreased effectiveness. Typically reserved for short-term or adjunctive therapy.

A

Benzodiazepines: Tolerance and Long-Term Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Blocks voltage-gated sodium channels, stabilizing neuronal membranes and preventing repetitive firing.

A

Phenytoin: Mechanism of Action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fosphenytoin is a water-soluble prodrug of phenytoin, safer for IV/IM use with fewer infusion-related complications.

A

Fosphenytoin vs. Phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Binds to synaptic vesicle protein SV2A. Minimal drug interactions, renally excreted, fewer cognitive side effects. May cause mood changes.

A

Levetiracetam: MOA and Clinical Advantages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Selection based on seizure type, side effect profile, drug interactions, and patient-specific factors.

A

Antiepileptic Drugs: Risks and Benefits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Highly protein-bound; nonlinear pharmacokinetics. Small dose changes can lead to large increases in serum levels.

A

Phenytoin: Distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Many anti-epileptic drugs induce or inhibit CYP enzymes. Phenytoin, carbamazepine, and phenobarbital are potent inducers.

A

Antiepileptics: Drug-Drug Interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Phenytoin, carbamazepine, topiramate, and clobazam can reduce effectiveness of hormonal contraceptives by increasing metabolism.

A

AEDs and Contraceptives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Inhibit breakdown of acetylcholine, enhancing cholinergic transmission. Used for mild to moderate Alzheimer’s disease.

A

Acetylcholinesterase Inhibitors: Role in AD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Donepezil (daily dosing), rivastigmine (oral and patch, used in PD-related dementia), galantamine (dual MOA).

A

AChE Inhibitors: Common Agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GI effects (nausea, diarrhea), bradycardia, syncope, muscle cramps. Risk of falls due to vagotonic effects.

A

AChE Inhibitors: Adverse Effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anticholinergics reduce efficacy; beta-blockers increase bradycardia risk. Monitor for GI effects and syncope.

A

AChE Inhibitors: Interactions and Monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Memantine blocks NMDA receptors to prevent excitotoxicity from excess calcium influx. Used in moderate to severe AD.

A

NMDA Receptor Antagonist: Role in AD

17
Q

Generally well tolerated. May cause agitation, confusion, dizziness, and headache, which may be difficult to differentiate from AD symptoms.

A

Memantine: Adverse Effects

18
Q

Topiramate and divalproex are effective options. Start low and titrate to avoid side effects.

A

AEDs in Migraine Prevention

19
Q

Cognitive dysfunction, paresthesia, fatigue, weight loss, kidney stones, and glaucoma.

A

Topiramate: Adverse Effects

20
Q

Hepatotoxicity, pancreatitis, teratogenicity (neural tube defects). Common side effects include nausea, tremor, weight gain.

A

Valproate: Adverse Effects and Black Box Warnings

21
Q

Avoid valproate due to teratogenic risk. Counsel on contraception and folic acid supplementation.

A

Migraine AED Use in Reproductive-Age Patients

22
Q

Topiramate blocks sodium channels and enhances GABA. Divalproex increases GABA availability and suppresses neuronal firing.

A

Topiramate and Divalproex: MOA in Migraine

23
Q

May reduce frequency and intensity of attacks by up to 50–70%. Benefits begin within weeks; maximum effect may take months.

A

Migraine Prevention: Efficacy and Onset

24
Q

Includes weight changes, fatigue, cognitive changes, and teratogenicity. Monitor patients closely for tolerability.

A

Migraine Prevention: Adverse Effects

25
Used to prevent neural tube defects in patients of childbearing potential taking AEDs.
Folic Acid: Indications in Epilepsy
26
1–5 mg daily before conception and during pregnancy to reduce teratogenic risks.
Folic Acid: Dosing and Timing
27
Valproate, phenobarbital, and carbamazepine. Avoid in pregnancy if possible.
AEDs with High Teratogenic Risk
28
Levodopa is converted to dopamine in the CNS; carbidopa inhibits peripheral breakdown of levodopa, increasing CNS availability.
Carbidopa-Levodopa: MOA
29
Absorbed in small intestine; high-protein meals decrease absorption. Short half-life contributes to motor fluctuations.
Carbidopa-Levodopa: Absorption and Metabolism
30
Fluctuating response to levodopa in advanced PD. 'Off' periods marked by immobility despite dosing.
Carbidopa-Levodopa: On-Off Phenomenon
31
GI (nausea, vomiting), CV (orthostatic hypotension, arrhythmias), psychiatric (hallucinations, psychosis, impulse control disorders).
Carbidopa-Levodopa: Adverse Effects
32
Administer on empty stomach, 30 minutes before meals to improve absorption.
Carbidopa-Levodopa: Timing of Dosing
33
Caution in cardiac disease and psychiatric illness. Avoid with nonselective MAOIs due to risk of hypertensive crisis.
Carbidopa-Levodopa: Contraindications
34
Selective 5-HT1B/1D receptor agonists. Cause vasoconstriction and inhibit CGRP release to terminate migraine attacks.
Triptans: MOA
35
Used at onset of moderate to severe migraine. Best efficacy when taken early in the attack.
Triptans: Clinical Use
36
Ischemic heart disease, uncontrolled hypertension, pregnancy. Avoid in patients with significant cardiovascular risk.
Triptans: Contraindications
37
Chest tightness, flushing, dizziness, bad taste (nasal forms), coronary vasospasm (rare but serious).
Triptans: Adverse Effects
38
Avoid co-administration with SSRIs, SNRIs, MAOIs, or ergot derivatives due to serotonin syndrome risk.
Triptans: Drug Interactions